Viewing Study NCT06591754



Ignite Creation Date: 2024-10-26 @ 3:40 PM
Last Modification Date: 2024-10-26 @ 3:40 PM
Study NCT ID: NCT06591754
Status: ENROLLING_BY_INVITATION
Last Update Posted: None
First Post: 2024-09-08

Brief Title: Feasibility Acceptability and Preliminary Effects of ISTDP for Personality Disorders in a Specialized Psychiatric Clinic
Sponsor: None
Organization: None

Study Overview

Official Title: A Pilotstudy Investigating Feasability Acceptability and Preliminary Effects of ISTDP Intensive Short Term Dynamic Psychotherapy for Patients with Personality Disorder in a Psychiatric Clinic Specialized on Depression Anxiety and PTSD
Status: ENROLLING_BY_INVITATION
Status Verified Date: 2024-09
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: No
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: The primary objective of this study is to evaluate the feasibility and acceptability of a 25-week combined group and individual therapy program using Intensive Short-Term Dynamic Psychotherapy ISTDP for patients diagnosed with personality disorders The secondary objective is to investigate preliminary effects of the treatment in terms of reducing symtoms of depression anxiety and emotion regulation difficulties
Detailed Description: The investigators vill investigate a 25-week treatment with ISTDP that consists of both weekly group- and individual therapy for patients diagnosed with personality disorder in a psychiatric clinic specialized on depression anxiety and PTSD The feasibility and acceptability and preliminary effects will be evaluated using a within-group design with repeated measures and qualitative interviews Patients will be recruited from the clinic and the main inclusion criteria is that the patient have a personality disorder diagnosis

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None